Mazankowski Alberta Heart Institute (MAHI) EchoGo Discovery 1 Protocol

计划入组 250 人 · 首次发布于 2021 年 5 月 7 日

Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes

计划入组 800 人 · 首次发布于 2024 年 9 月 19 日

Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus

计划入组 49 人 · 首次发布于 2012 年 5 月 8 日

N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE

C₁₅H₁₃ClIN₃O₂

BLUE ECHO CARE LLC

United States

ECHO THERAPEUTICS PTY LTD

Australia

Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection

Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection

FDA Clears AI-Powered Ultrasound Software EchoGo® Amyloidosis for Enhanced Cardiac Amyloidosis Detection